Your browser doesn't support javascript.
loading
Arteriolar neuropathology in cerebral microvascular disease.
Fang, Chuo; Magaki, Shino D; Kim, Ronald C; Kalaria, Raj N; Vinters, Harry V; Fisher, Mark.
Affiliation
  • Fang C; Department of Neurology, University of California, Irvine Medical Center, 101 The City Drive South Shanbrom Hall (Building 55), Room 121, Orange, 92868, California, USA.
  • Magaki SD; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Kim RC; Department of Pathology & Laboratory Medicine, University of California, Irvine, Orange, California, USA.
  • Kalaria RN; Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK.
  • Vinters HV; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Fisher M; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Neuropathol Appl Neurobiol ; 49(1): e12875, 2023 02.
Article in En | MEDLINE | ID: mdl-36564356
ABSTRACT
Cerebral microvascular disease (MVD) is an important cause of vascular cognitive impairment. MVD is heterogeneous in aetiology, ranging from universal ageing to the sporadic (hypertension, sporadic cerebral amyloid angiopathy [CAA] and chronic kidney disease) and the genetic (e.g., familial CAA, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL] and cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy [CARASIL]). The brain parenchymal consequences of MVD predominantly consist of lacunar infarcts (lacunes), microinfarcts, white matter disease of ageing and microhaemorrhages. MVD is characterised by substantial arteriolar neuropathology involving ubiquitous vascular smooth muscle cell (SMC) abnormalities. Cerebral MVD is characterised by a wide variety of arteriolar injuries but only a limited number of parenchymal manifestations. We reason that the cerebral arteriole plays a dominant role in the pathogenesis of each type of MVD. Perturbations in signalling and function (i.e., changes in proliferation, apoptosis, phenotypic switch and migration of SMC) are prominent in the pathogenesis of cerebral MVD, making 'cerebral angiomyopathy' an appropriate term to describe the spectrum of pathologic abnormalities. The evidence suggests that the cerebral arteriole acts as both source and mediator of parenchymal injury in MVD.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Cerebral Amyloid Angiopathy / CADASIL / Neuromuscular Diseases Limits: Humans Language: En Journal: Neuropathol Appl Neurobiol Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Cerebral Amyloid Angiopathy / CADASIL / Neuromuscular Diseases Limits: Humans Language: En Journal: Neuropathol Appl Neurobiol Year: 2023 Type: Article Affiliation country: United States